BioForum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
BioForum
« Previous
123
Next »

Innovation Boom Towns

June 2, 2012
By: Christopher Milne
Pharmaceutical Technology

Partnerships between industry and academic medical centers are expanding to meet R&D needs.

A Sustainable Biotech Path

April 2, 2012
By: Glen Giovannetti
Pharmaceutical Technology

With financing constrained, biotechnology firms must find ways to sustain innovation.

Defining Conflict of Interest

March 2, 2012
By: Christopher Milne
Pharmaceutical Technology

The divide between innovation and conflict of interest in medical research is not so clear.

Single-Use High Capacity Membrane Chromatography

February 2, 2012
By: Carl Lawton
Pharmaceutical Technology

Debottlenecking downstream mAb purification.

Venture-Capital Funding Falls but Shows Some Momentum

January 2, 2012
By: Tracy T. Lefteroff
Pharmaceutical Technology

Challenges remain, particularly for early-stage biopharmaceutical companies.

Creating Innovation Nodes to Meet Unmet Medical Needs

December 2, 2011
By: Kenneth I. Kaitin
Pharmaceutical Technology

Pharma companies must balance demand for new drugs while facing reduced R&D spending.

Growth for Small Pharma

November 2, 2011
By: Mauli Teli, Vinita Vasanth, Dinkar Saran
Pharmaceutical Technology

Small drug companies with hopes of achieving $1 billion in sales can pursue various strategies.

Biotech Venture Funding Slips Below 2010 Levels

October 2, 2011
By: Tracey T. Lefteroff
Pharmaceutical Technology

Average deal size and amounts invested increased in the second quarter, but totals trail funding of last year.

Embarking on the New World of Personalized Medicine

August 2, 2011
By: Albert S. Lee, Ash Malik, Mark A. Mynhier
Pharmaceutical Technology

A path to personalized medicines creates a new paradigm for development and manufacturing.

« Previous
123
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here